Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells

Cancer Research

Volumn 57, Issue 14, 1997, Pages 2865-2869

  Ribas, Antoni ^a   Butterfield, Lisa H ^a   McBride, William H ^a   Jilani, Syed M ^a   Bui, Lynne A ^a   Vollmer, Charles M ^a   Lau, Roy ^a   Dissette, Vivian B ^a   Hu, Billy ^a   Chen, Angela Y ^a   Glaspy, John A ^a   Economou, James S ^a,b  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; MELANOMA ANTIGEN; MESSENGER RNA;

ADENOVIRUS; ANIMAL CELL; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENE THERAPY; IMMUNIZATION; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; ANTIGENS, NEOPLASM; DENDRITIC CELLS; FEMALE; GENE THERAPY; HUMANS; IMMUNIZATION; MICE; MICE, INBRED C3H; NEOPLASM PROTEINS; NEOPLASMS; TRANSFECTION;

EID: 0030848375     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Traversari, C., van der Bruggen, P., Lulescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., and Boon, T. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytotoxic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med., 176: 1453-1457, 1992.
2. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., and Rosenberg, S. A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA, 91: 3515-3519, 1994.
3. Coulie, P. G., Brichard, V., Van Pel, A., Wolfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C. Szikora, J. P., Renauld, J. C., and Boon, T. A new gene coding for a differentiation antigen recognized by autologous cytotoxic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 180: 35-42, 1994.
4. Steinman, R. M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol., 9: 271-296, 1991.
5. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., and Steinman, R. M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med., 176: 1693-1702, 1992.
6. Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T., Martin Kast, W., Deleo, A. B., and Lotze, M. T. Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nat. Med., 1: 1297-1302, 1995.
7. Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T., and Storkus, W. J. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper 1-associated cytokines. J. Exp. Med., 183: 287-297, 1996.
8. Mayordomo, J. I., Loftus, D. J., Sakamoto, H., De Cesare, C. M., Appasamy, P. M., Lotze, M. T., Storkus, W. J., Appella, E., and DeLeo, A. B. Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines. J. Exp. Med., 183: 1357-1365, 1996.
9. Arthur, J. F., Butterfield, L. H., Kiertscher, S. M., Roth, M. D., Bui, L. A., Lau, R., Dubinett, S., Glaspy, J., and Economou, J. S. A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther., 4: 17-25, 1997.
10. Millas, L., Wike, J., Hunter, N., Volpe, J., and Basic, I. Macrophage content of murine sarcomas and carcinomas: associations with tumor growth parameters and tumor radiocurability. Cancer Res., 47: 1069-1075, 1987.
11. Butterfield, L. H., Stoll, T., Lau, R., and Economou, J. S. Cloning and analysis of MART-1/Melan-A human melanoma antigen promoter regions. Gene (Amst.), in press, 1997.
12. Doe, B., Selby, M., Barnett, S., Baenziger, J., and Walker, C. H. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA, 93: 8578-8583, 1996.
13. Corr, M., Lee, D. J., Carson, D. A., and Tighe, H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med., 184: 1555-1560, 1996.
14. Zhai, Y., Yang, J. C., Kawakami, Y., Spiess, P., Wadsworth, S. C., Cardoza, L. M., Couture, L. A., Smith, A. E., and Rosenbert, S. A. Antigen-specific tumor vaccines: development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy. J. Immunol., 156: 700-710, 1996.
15. Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, T., Meny, G. M., Nadaf, S., Kavanaugh, D., and Carbone, D. P. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med., 2: 1096-1103, 1996.
16. Gabrilovich, D. I., Kavanaugh, D., Corak, J., Nadaf-Rahrov, S., Cunningham, T., and Carbone, D. P. Defective function of dendritic cells in patients with breast cancer can be overcome by generation of these cells from precursors, a new approach to cancer immunotherapy. Proc. Am. Soc. Clin. Oncol., 15: 354, 1996.
17. Reeves, M. E., Royalo, R. E., Lam, J. S., Rosenberg, S. A., and Hwo, P. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res., 56: 5672-5677, 1996.
18. Marincola, F. M., Rivoltini, L., Salgaller, M. L., Player, M., and Rosenberg, S. A. Differential anti-MART-1/MelanA CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison to healthy donors: evidence of in vivo priming by tumor cells. J. Immunother., 19: 266-277, 1996.